Illicit cocaine and methamphetamine containing opioids
Following ongoing identification of cases of opioid overdose after use of substances expected to be cocaine or methamphetamine in NSW, a Safety Notice for Clinicians (012/26) has been published on the NSW Health website. The Safety Notice will also be distributed via the Clinical Excellence Commission’s Safety Alert Broadcast System.
Additionally, one person has died and multiple people in four separate incidents across Victoria have required emergency care because they experienced heroin overdose after using what they thought was cocaine or methamphetamine. Specialised blood tests showed evidence of heroin as well as cocaine and methamphetamine, suggesting that heroin may have been mixed into these drugs (‘adulteration’).
Please see the drug alert issued by the Victorian Department of Health.
Please share this information with your patients, peers, clients, and professional networks as appropriate.
Know the signs of opioid overdose and access naloxone
Signs of opioid overdose include breathing slowly and reduced consciousness (meaning someone is hard to wake up). In some cases, the person may also have tiny pupils. More information about opioid overdose symptoms can be found on the Penington Institute website.
Naloxone is a life-saving medicine that can temporarily reverse an opioid overdose. Naloxone is available in an easy to use nasal spray, and as a pre-filled injection.
New universal antenatal syphilis screen introduced at 36 weeks gestation NSW Health has updated the Policy Directive Syphilis in Pregnancy and Newborns (PD2026_044) to strengthen the prevention of congenital syphilis and align with the updated Australian Pregnancy Care Guidelines. Under the revised Policy Directive, syphilis screening should be offered to…
SESLHD State-Wide Referral Criteria (SRC) SESLHD is preparing to implement the next phase of the NSW Statewide Referral Criteria (SRC) for referrals to public hospital outpatient services. The SRC establishes consistent clinical referral requirements across NSW, helping general practitioners and other referrers to: Determine when referral to a public outpatient…
Immunisation Weekly Update: Welcome to our weekly Immunisation Update! In this week’s update, read about: COVID-19 vaccination in 2026: preparing for the transition to the National Immunisation Program (NIP) Webinar COVID-19 vaccine stock RSV now Australia’s most notified respiratory virus: a timely reminder to check vaccine status Education COVID-19 vaccination…
New NSW medicines and poisons legislation commences 5 November 2026 New NSW medicines and poisons legislation will commence on 5 November 2026, replacing the current regulatory framework with the Medicines, Poisons and Therapeutic Goods Act 2022 and the Medicines, Poisons and Therapeutic Goods Regulation 2026. The changes introduce new requirements…
Immunisation Weekly Update: Welcome to our weekly Immunisation Update! In this week’s update, read about: Transition of COVID-19 vaccines to the NIP Hep B vaccine eligibility No link between vaccines and autism Expansion of the NIP Vaccinations in Pharmacy Program to include children under 5 years National Vaccination Insights project…
HealthPathways is getting a refreshed look From 17 September 2026, HealthPathways Sydney and South Eastern Sydney sites will launch a refreshed layout designed to provide a clearer and more user-friendly experience. New features: Simplified homepage More prominent search bar Improved toolbar for common actions – including CPD notes and expand/collapse…